| CNR2 |
CNR2: Cannabinoid receptor 2 |
GPR26 |
GPR26: Probable G-protein coupled receptor 26 |
0.745 |
Evidence |
|
| SSTR3 |
SSTR3: Somatostatin receptor type 3 |
C9orf47 |
EDG3: Sphingosine 1-phosphate receptor Edg-3 |
0.745 |
Evidence |
|
| SSTR3 |
SSTR3: Somatostatin receptor type 3 |
XCR1 |
XCR1, CCXCR1, GPR5: Chemokine XC receptor 1 |
0.745 |
Evidence |
|
| BLR1 |
BLR1, CXCR5, MDR15: C-X-C chemokine receptor type 5 |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
0.745 |
Evidence |
|
| BLR1 |
BLR1, CXCR5, MDR15: C-X-C chemokine receptor type 5 |
OR8B8 |
OR8B8: Olfactory receptor 8B8 |
0.745 |
Evidence |
|
| BLR1 |
BLR1, CXCR5, MDR15: C-X-C chemokine receptor type 5 |
OR51B4 |
OR51B4: Olfactory receptor 51B4 |
0.745 |
Evidence |
|
| BLR1 |
BLR1, CXCR5, MDR15: C-X-C chemokine receptor type 5 |
C9orf47 |
EDG3: Sphingosine 1-phosphate receptor Edg-3 |
0.745 |
Evidence |
|
| BLR1 |
BLR1, CXCR5, MDR15: C-X-C chemokine receptor type 5 |
GPR103 |
GPR103: Orexigenic neuropeptide QRFP receptor |
0.745 |
Evidence |
|
| BLR1 |
BLR1, CXCR5, MDR15: C-X-C chemokine receptor type 5 |
OR51E1 |
Dresden-G-protein-coupled receptor |
0.745 |
Evidence |
|
| CCR7 |
CCR7, CMKBR7, EBI1, EVI1: C-C chemokine receptor type 7 precursor |
FAM62A |
FAM62A, KIAA0747, MBC2: Protein FAM62A |
0.745 |
Evidence |
|
| CCR7 |
CCR7, CMKBR7, EBI1, EVI1: C-C chemokine receptor type 7 precursor |
GPR62 |
GPR62: Probable G-protein coupled receptor 62 |
0.745 |
Evidence |
|
| CCR7 |
CCR7, CMKBR7, EBI1, EVI1: C-C chemokine receptor type 7 precursor |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
0.745 |
Evidence |
|
| BRS3 |
BRS3: Bombesin receptor subtype-3 |
OR1A1 |
OR1A1: Olfactory receptor 1A1 |
0.745 |
Evidence |
|
| CCR1 |
CCR1, CMKBR1, CMKR1, SCYAR1: C-C chemokine receptor type 1 |
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
0.745 |
Evidence |
|
| CCKAR |
CCKAR, CCKRA: Cholecystokinin receptor type A |
GPR146 |
GPR146, PGR8: Probable G-protein coupled receptor 146 |
0.745 |
Evidence |
|
| CCKAR |
CCKAR, CCKRA: Cholecystokinin receptor type A |
RXFP4 |
RXFP4, GPR100, RLN3R2: Relaxin-3 receptor 2 |
0.745 |
Evidence |
|
| S100A7 |
S100A7, PSOR1: Protein S100-A7 |
DTNB |
DTNB: Dystrobrevin beta |
0.745 |
Evidence |
|
| PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
KHDRBS3 |
KHDRBS3, SALP, SLM2: KH domain-containing, RNA-binding, signal transduction-asso |
0.745 |
Evidence |
|
| NMBR |
NMBR: Neuromedin-B receptor |
GPR55 |
GPR55: Probable G-protein coupled receptor 55 |
0.745 |
Evidence |
|
| NMBR |
NMBR: Neuromedin-B receptor |
GPR141 |
GPR141, PGR13: Probable G-protein coupled receptor 141 |
0.745 |
Evidence |
|
| NMBR |
NMBR: Neuromedin-B receptor |
GPR142 |
GPR142, PGR2: Probable G-protein coupled receptor 142 |
0.745 |
Evidence |
|
| NMBR |
NMBR: Neuromedin-B receptor |
GPR162 |
GPR162, GRCA: Probable G-protein coupled receptor 162 |
0.745 |
Evidence |
|
| CD40 |
CD40, TNFRSF5: Tumor necrosis factor receptor superfamily member 5 precursor |
TNFRSF9 |
TNFRSF9, CD137, ILA: Tumor necrosis factor receptor superfamily member 9 precurs |
0.745 |
Evidence |
|
| CD40 |
CD40, TNFRSF5: Tumor necrosis factor receptor superfamily member 5 precursor |
LTBR |
LTBR, D12S370, TNFCR, TNFRSF3: Tumor necrosis factor receptor superfamily member |
0.745 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
OR8B8 |
OR8B8: Olfactory receptor 8B8 |
0.745 |
Evidence |
|